3 Biotech Stocks to Buy for the mRNA Revolution October 01 2022 - 04:47AM TipRanks
An experience that few want to relive is the COVID-19 crisis. Though the disruptions it imposed may reverberate for years to come, it also sparked a major silver lining: the development and distribution of messenger-RNA-based vaccines. Indeed, advanced biotechnology firms may be able to leverage this innovation to spark additional therapeutics. In particular, patient forward-looking investors may want to consider the following biotech stocks: BioNTech (NASDAQ:BNTX) CureVac (NASDAQ:CVAC) Arcturus Therapeutics (NASDAQ:ARCT) During the initial development phase of mRNA vaccines for the SARS-CoV-2 virus, public hesitancy arose due to the “newness” factor of the innovative approach. https://www.tipranks.com/news/article/3-biotech-stocks-to-buy-on-rna-revolution-bntx-cvac-arct?utm_source=advfn.com&utm_medium=referral
Market Data 
Markets 
AI
